Focused Ultrasound Personalized Therapy for the Treatment of Depression (UPSIDE)
The UPSIDE project aims to develop a minimally invasive hybrid neurotechnology for targeted brain stimulation and biomarker monitoring to enhance treatment for Treatment-Resistant Depression.
Projectdetails
Introduction
Major depressive disorder (MDD) is the leading cause of disability worldwide, affecting 300 million people with a lifetime prevalence of 15%. Approximately one third of all MDD patients fail to respond to currently established treatments based on medication and psychotherapy, thus falling into the category of Treatment-Resistant Depression (TRD) patients.
Current Treatment Limitations
Electroconvulsive therapy (ECT), repetitive Transcranial Magnetic Stimulation (tRMS), Vagus nerve stimulation (VNS), deep brain stimulation (DBS), and transcranial focused ultrasound (tFUS) still show:
- Poor spatial resolution (ECT, tRMS, tFUS)
- Low network coverage (VNS, DBS)
With average remission rates in clinical trials still lower than 30%.
Need for Biomarkers
Apart from the existing stimulation hurdles, reliable biomarkers for depression are needed as a diagnostic tool. In the case of neurotechnology (NT), these biomarkers can help determine stimulation efficacy and allow for personalized treatment.
Project Overview
The UPSIDE project proposes a minimally invasive, high spatial resolution, and multi-brain region stimulation and recording system to largely exceed the capabilities of existing NT for depression.
Objectives
Our objective is to research and validate in vivo a hybrid neurotechnology consisting of:
- An epidural focused ultrasound (eFUS) stimulator employing three-dimensional beamforming
- A high-density epidural EEG recording system
Technological Innovations
Epidural deployment of these devices will be enabled by novel methods for:
- Massive integration and miniaturization of high-performing piezoelectric ultrasound materials
- High-fidelity organic bioelectronic materials
- High energy-efficient complementary metal-oxide semiconductor (CMOS) technology in a biocompatible manner
Expected Outcomes
The UPSIDE project will result in a demonstrator which will allow, for the first time, network stimulation and simultaneous biomarker readout in behavioral experiments with animal models featuring depression-like symptoms.
This technological breakthrough will pave the way towards a personalized treatment for TRD.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 4.149.921 |
Totale projectbegroting | € 4.149.921 |
Tijdlijn
Startdatum | 1-9-2022 |
Einddatum | 31-8-2026 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- TECHNISCHE UNIVERSITEIT DELFTpenvoerder
- UNIVERSITEIT GENT
- UNIVERSITAETSKLINIKUM FREIBURG
- NEWRONIKA SPA
- SILICONGATE LDA
- Micro Systems Technologies Management GmbH
- FOCUSED ULTRASOUND FOUNDATION
Land(en)
Vergelijkbare projecten binnen EIC Pathfinder
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
A multiplexed biomimetic imaging platform for assessing single cell plasticity (Plastomics) and scoring of tumour malignancyThe PLAST_CELL project aims to develop a microfluidics-based imaging platform to quantify cancer cell plasticity, enhancing diagnosis and treatment of metastasis and therapy resistance. | EIC Pathfinder | € 2.982.792 | 2022 | Details |
"Creation of innovative ""humidity to electricity"" renewable energy conversion technology towards sustainable energy challenge"The CATCHER project aims to develop scalable technology for converting atmospheric humidity into renewable electricity, enhancing EU leadership in clean energy innovation. | EIC Pathfinder | € 2.996.550 | 2022 | Details |
Smart Electronic Olfaction for Body Odor DiagnosticsSMELLODI aims to digitize and synthesize olfactory information for remote disease diagnostics and assist individuals with olfactory disorders using advanced sensor technology and machine learning. | EIC Pathfinder | € 3.263.781 | 2022 | Details |
Quantitative Ultrasound Stochastic Tomography - Revolutionizing breast cancer diagnosis and screening with supercomputing-based radiation-free imaging.The project aims to revolutionize breast cancer imaging by developing adjoint-based algorithms for uncertainty quantification, enhancing diagnostic confidence through high-resolution, radiation-free images. | EIC Pathfinder | € 2.744.300 | 2022 | Details |
A multiplexed biomimetic imaging platform for assessing single cell plasticity (Plastomics) and scoring of tumour malignancy
The PLAST_CELL project aims to develop a microfluidics-based imaging platform to quantify cancer cell plasticity, enhancing diagnosis and treatment of metastasis and therapy resistance.
"Creation of innovative ""humidity to electricity"" renewable energy conversion technology towards sustainable energy challenge"
The CATCHER project aims to develop scalable technology for converting atmospheric humidity into renewable electricity, enhancing EU leadership in clean energy innovation.
Smart Electronic Olfaction for Body Odor Diagnostics
SMELLODI aims to digitize and synthesize olfactory information for remote disease diagnostics and assist individuals with olfactory disorders using advanced sensor technology and machine learning.
Quantitative Ultrasound Stochastic Tomography - Revolutionizing breast cancer diagnosis and screening with supercomputing-based radiation-free imaging.
The project aims to revolutionize breast cancer imaging by developing adjoint-based algorithms for uncertainty quantification, enhancing diagnostic confidence through high-resolution, radiation-free images.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Deep Brain Neuromodulation using Temporal Interference Magnetic StimulationDevelop a non-invasive tool using temporal interference magnetic stimulation for precise modulation of neural activity in the brain, aiming to improve treatment options for brain disorders. | ERC POC | € 150.000 | 2022 | Details |
Bidirectional Brain/Neural-Computer Interaction for Restoration of Mental HealthThis project aims to develop a portable neuromodulation system using quantum sensors and magnetic stimulation to precisely target brain oscillations for treating mental health disorders. | ERC COG | € 1.999.875 | 2025 | Details |
Dissecting the biophysical mechanisms of deep brain stimulation using voltage fluorescence microscopyThis project aims to elucidate the cellular mechanisms of deep brain stimulation in epilepsy using a novel optical technique to improve therapeutic protocols for human patients. | ERC STG | € 1.498.729 | 2024 | Details |
Minimally invasive and closed-loop ultrasound neuromodulation and recording for the treatment of focal epilepsyThis project aims to develop a minimally invasive, closed-loop ultrasound neuromodulation system for treating refractory epilepsy, optimizing protocols through a comprehensive computational framework. | ERC STG | € 1.499.575 | 2025 | Details |
Deep Brain Neuromodulation using Temporal Interference Magnetic Stimulation
Develop a non-invasive tool using temporal interference magnetic stimulation for precise modulation of neural activity in the brain, aiming to improve treatment options for brain disorders.
Bidirectional Brain/Neural-Computer Interaction for Restoration of Mental Health
This project aims to develop a portable neuromodulation system using quantum sensors and magnetic stimulation to precisely target brain oscillations for treating mental health disorders.
Dissecting the biophysical mechanisms of deep brain stimulation using voltage fluorescence microscopy
This project aims to elucidate the cellular mechanisms of deep brain stimulation in epilepsy using a novel optical technique to improve therapeutic protocols for human patients.
Minimally invasive and closed-loop ultrasound neuromodulation and recording for the treatment of focal epilepsy
This project aims to develop a minimally invasive, closed-loop ultrasound neuromodulation system for treating refractory epilepsy, optimizing protocols through a comprehensive computational framework.